GB9825374D0 - Method - Google Patents

Method

Info

Publication number
GB9825374D0
GB9825374D0 GBGB9825374.3A GB9825374A GB9825374D0 GB 9825374 D0 GB9825374 D0 GB 9825374D0 GB 9825374 A GB9825374 A GB 9825374A GB 9825374 D0 GB9825374 D0 GB 9825374D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9825374.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PPL Therapeutics Scotland Ltd
Original Assignee
PPL Therapeutics Scotland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PPL Therapeutics Scotland Ltd filed Critical PPL Therapeutics Scotland Ltd
Priority to GBGB9825374.3A priority Critical patent/GB9825374D0/en
Publication of GB9825374D0 publication Critical patent/GB9825374D0/en
Priority to DE69940700T priority patent/DE69940700D1/en
Priority to CA002351943A priority patent/CA2351943A1/en
Priority to AU13956/00A priority patent/AU765315B2/en
Priority to PCT/GB1999/003868 priority patent/WO2000030436A1/en
Priority to JP2000583334A priority patent/JP4833409B2/en
Priority to NZ511299A priority patent/NZ511299A/en
Priority to EP99972491A priority patent/EP1130961B1/en
Priority to AT99972491T priority patent/ATE427653T1/en
Priority to US09/861,399 priority patent/US7030289B2/en
Priority to JP2011061142A priority patent/JP2011167196A/en
Ceased legal-status Critical Current

Links

GBGB9825374.3A 1998-11-19 1998-11-19 Method Ceased GB9825374D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB9825374.3A GB9825374D0 (en) 1998-11-19 1998-11-19 Method
AT99972491T ATE427653T1 (en) 1998-11-19 1999-11-19 STABILIZATION OF MILK FROM TRANSGENIC ANIMALS
PCT/GB1999/003868 WO2000030436A1 (en) 1998-11-19 1999-11-19 Stabilisation of milk from transgenic animals
CA002351943A CA2351943A1 (en) 1998-11-19 1999-11-19 Stabilisation of milk from transgenic animals
AU13956/00A AU765315B2 (en) 1998-11-19 1999-11-19 Stabilisation of milk from transgenic animals
DE69940700T DE69940700D1 (en) 1998-11-19 1999-11-19 STABILIZATION OF MILK TRANSGENER PETS
JP2000583334A JP4833409B2 (en) 1998-11-19 1999-11-19 Stabilization of milk in transgenic animals
NZ511299A NZ511299A (en) 1998-11-19 1999-11-19 Stabilisation of milk from transgenic animals through expression of a serine proteinase inhibitor and optionally fibrinogen in the mammary gland
EP99972491A EP1130961B1 (en) 1998-11-19 1999-11-19 Stabilisation of milk from transgenic animals
US09/861,399 US7030289B2 (en) 1998-11-19 2001-05-18 Stabilization of milk from transgenic animals
JP2011061142A JP2011167196A (en) 1998-11-19 2011-03-18 Stabilization of milk from transgenic animal

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9825374.3A GB9825374D0 (en) 1998-11-19 1998-11-19 Method

Publications (1)

Publication Number Publication Date
GB9825374D0 true GB9825374D0 (en) 1999-01-13

Family

ID=10842718

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9825374.3A Ceased GB9825374D0 (en) 1998-11-19 1998-11-19 Method

Country Status (2)

Country Link
JP (1) JP4833409B2 (en)
GB (1) GB9825374D0 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2719505T3 (en) * 2013-12-27 2019-07-10 Japan Blood Products Organization Highly producing line of recombinant fibrinogen and method for its production

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5598196A (en) * 1979-01-16 1980-07-25 Meito Sangyo Kk Fractionation of fibrinogen or its constituents and their use
EP0169114B1 (en) * 1984-06-19 1991-01-16 Transgene S.A. Human alpha-1-antitrypin derivatives and process for their preparation
JP2769170B2 (en) * 1987-12-08 1998-06-25 ザイモジェネティクス，インコーポレイティド Simultaneous expression in eukaryotic fat
DE69535604T2 (en) * 1994-02-18 2008-05-21 American National Red Cross TRANSGENIC FIBRINOGEN
US5639940A (en) * 1994-03-03 1997-06-17 Pharmaceutical Proteins Ltd. Production of fibrinogen in transgenic animals
US5723579A (en) * 1996-02-02 1998-03-03 Bayer Corporation Fibrinogen binding peptides
JP2001522230A (en) * 1997-02-14 2001-11-13 アメリカン・レツド・クロス Expression of active human factor IX in breast tissue of transgenic animals

Also Published As

Publication number Publication date
JP4833409B2 (en) 2011-12-07
JP2002530093A (en) 2002-09-17

Similar Documents

Publication Publication Date Title
GB9809414D0 (en) Method
GB9809776D0 (en) Method
GB9819764D0 (en) Method
GB9810722D0 (en) Method
GB9814055D0 (en) Method
GB9802475D0 (en) Method
GB9819769D0 (en) Method
GB9817266D0 (en) Method
GB9824321D0 (en) Method
GB9820185D0 (en) Method
GB9821225D0 (en) Method
GB9809780D0 (en) Method
GB9809782D0 (en) Method
GB9821038D0 (en) Method
GB9825374D0 (en) Method
GB9804355D0 (en) Method
GB9823963D0 (en) Method
GB9811185D0 (en) Method
GB9816819D0 (en) Method
GB9813089D0 (en) Method
GB9813126D0 (en) Method
GB9813795D0 (en) Method
GB9811977D0 (en) Method
GB9801271D0 (en) Method
GB9811088D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)